Mechanical plus oral bowel preparation with paromomycin and metronidazole reduces infectious complications in elective colorectal surgery: a matched case-control study.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Sep 2021
Historique:
accepted: 12 04 2021
pubmed: 26 4 2021
medline: 11 8 2021
entrez: 25 4 2021
Statut: ppublish

Résumé

Infectious complications are as high as 30% in elective colorectal surgery. In recent years, several studies have discussed the topic of preoperative bowel decontamination prior to colorectal surgery in order to reduce postoperative infectious complications and have found significant effects of oral antibiotic administration with a large variety of drugs used. No study has evaluated the combination of oral paromomycin and metronidazole in this context. We performed a prospective single-center study with a matched-pair retrospective cohort to evaluate postoperative infectious complications (superficial site infections, organ space abscess, anastomotic leakage) in elective colorectal surgery. A total of 120 patients were available for study inclusion; 101 gave informed consent and were included. A total of 92 patients were matched and subsequently analyzed. We could show a reduction in overall infectious complications in the intervention group (15.2% vs 30.8%, p = 0.018; odds ratio 0.333, 95% CI 0.142-0.784) as well as a reduction in superficial surgical site infections (8.7 vs 19.6%, p = 0.041, OR 0.333, 95% CI 0.121-0.917). The frequency of the other infectious complications such as intraabdominal abscesses and anastomotic leakage showed a tendency towards decreased frequencies in the intervention group (OR 0.714, 95% CI 0.235-2.169 and OR 0.571; 95% CI 0.167-1.952, respectively). Finally, the oral antibiotic administration led to an almost significantly reduced length of stay (12.24 days vs 15.25 days; p = 0.057). Oral paromomycin and metronidazole with intravenous ertapenem effectively reduce infectious complications in elective colorectal surgery. The study was registered at Clinicaltrials.gov (NCT03759886) December 17, 2018.

Identifiants

pubmed: 33895874
doi: 10.1007/s00384-021-03931-9
pii: 10.1007/s00384-021-03931-9
pmc: PMC8346409
doi:

Substances chimiques

Anti-Bacterial Agents 0
Metronidazole 140QMO216E
Paromomycin 61JJC8N5ZK

Banques de données

ClinicalTrials.gov
['NCT03759886']

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1839-1849

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Dis Colon Rectum. 2017 Dec;60(12):1291-1298
pubmed: 29112565
Colorectal Dis. 2018 Jun;20(6):520-528
pubmed: 29045025
J Surg Res. 2019 Oct;242:183-192
pubmed: 31085366
Cir Esp. 2011 Nov;89(9):606-12
pubmed: 21820107
Dig Surg. 2020;37(3):192-198
pubmed: 31055568
Dis Colon Rectum. 2017 Jul;60(7):729-737
pubmed: 28594723
PLoS One. 2012;7(8):e44326
pubmed: 22952955
Br J Surg. 2019 Mar;106(4):355-363
pubmed: 30802304
Ann Surg. 2019 Apr;269(4):671-677
pubmed: 29064902
Ann Surg. 1983 Oct;198(4):525-30
pubmed: 6354113
Surgery. 2010 Mar;147(3):339-51
pubmed: 20004450
BJS Open. 2019 Oct 16;3(6):830-839
pubmed: 31832590
Can J Surg. 2002 Jun;45(3):173-80
pubmed: 12067168
Antimicrob Agents Chemother. 2004 Feb;48(2):521-4
pubmed: 14742204
Ann Surg. 2015 Aug;262(2):331-7
pubmed: 26083870
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):729-738
pubmed: 32325012
Infect Control Hosp Epidemiol. 2019 Aug;40(8):922-927
pubmed: 31196253
Antimicrob Resist Infect Control. 2020 Jun 15;9(1):84
pubmed: 32539786
J Am Coll Surg. 2013 Nov;217(5):763-9
pubmed: 24045142
World J Surg Oncol. 2020 Feb 11;18(1):35
pubmed: 32046725
BJS Open. 2018 May 10;2(4):185-194
pubmed: 30079387
Can J Surg. 2010 Dec;53(6):385-95
pubmed: 21092431
Ann Surg. 2015 Sep;262(3):416-25; discussion 423-5
pubmed: 26258310
Surg Infect (Larchmt). 2020 Feb;21(1):1-8
pubmed: 31361586
Sci Transl Med. 2015 May 6;7(286):286ra68
pubmed: 25947163
Ann R Coll Surg Engl. 2020 Feb;102(2):133-140
pubmed: 31508999
Br J Surg. 2011 Oct;98(10):1365-72
pubmed: 21751181
Ann Surg. 2016 Jun;263(6):1085-91
pubmed: 26756752
Br J Surg. 2021 Apr 5;108(3):271-276
pubmed: 33793743
Chirurg. 1981 Jun;52(6):398-402
pubmed: 6265162
BJS Open. 2018 May 10;2(4):238-245
pubmed: 30079393
Medicine (Baltimore). 2018 Sep;97(36):e12288
pubmed: 30200175
Lancet. 2019 Sep 7;394(10201):840-848
pubmed: 31402112
Int J Colorectal Dis. 2020 May;35(5):847-857
pubmed: 32103326
Clin Infect Dis. 2019 Jun 18;69(1):93-99
pubmed: 30281072
Int J Surg. 2016 Sep;33 Pt A:102-8
pubmed: 27463886
J Gastrointest Surg. 2018 Nov;22(11):1968-1975
pubmed: 29967968
Ann Surg. 2015 Jun;261(6):1034-40
pubmed: 25607761

Auteurs

Matthias Mehdorn (M)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, Leipzig University Hospital, Liebigstr. 20, D-04103, Leipzig, Germany.

Christoph Lübbert (C)

Division of Infectious Diseases and Tropical Medicine, Department of Medicine II, Leipzig University Hospital, Liebigstr. 20, D-04103, Leipzig, Germany.
Interdisciplinary Center for Infectious Disease (ZINF), Leipzig University Hospital, Liebigstr. 20, 22 04103, Leipzig, Germany.

Iris F Chaberny (IF)

Interdisciplinary Center for Infectious Disease (ZINF), Leipzig University Hospital, Liebigstr. 20, 22 04103, Leipzig, Germany.
Institute of Hygiene, Hospital Epidemiology and Environmental Medicine, Leipzig University Hospital, Liebigstr, 22 04103, Leipzig, Germany.

Ines Gockel (I)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, Leipzig University Hospital, Liebigstr. 20, D-04103, Leipzig, Germany.

Boris Jansen-Winkeln (B)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, Leipzig University Hospital, Liebigstr. 20, D-04103, Leipzig, Germany. Boris.Jansen-Winkeln@medizin.uni-leipzig.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH